🕵️ Sofgen Pharma S.A. ($PROC)
SEC insider & ownership activity, last 12 months · CIK 1863362 · every row links its SEC filing
Insiders were quiet over the last 12 months – no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Magnolia Management GP LLC | 84.4% | 13D | Apr 9, 2025 | filing ↗ | |
| Tomas Fernandez Mac Auliffe | 84.4% | 13D | Apr 9, 2025 | filing ↗ | |
| Eduardo Fernandez Mac Auliffe | 84.4% | 13D | Apr 9, 2025 | filing ↗ | |
| Flying FISH Ventures, L.P. | 84.4% | 13D | Apr 9, 2025 | filing ↗ | |
| Leonidas Vial Echeverria | 84.4% | 13D | Apr 9, 2025 | filing ↗ | |
| Saint Thomas Commercial S.a. | 84.4% | 13D | Apr 9, 2025 | filing ↗ | |
| Santana S.a. | 84.4% | 13D | Apr 9, 2025 | filing ↗ | |
| Hoche Partners Pharma Holding S.A. | 84.4% | 13D | Apr 16, 2025 | filing ↗ | |
| Becaril S.a. | 53.0% | 13D | Apr 9, 2025 | filing ↗ | |
| Chemo Project, S.A. | 53.0% | 13D | Apr 9, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
No 8-K filings in the last 12 months.